Trulee Health, LLC – Trademark Portfolio

Entity Type: 16

Trulee Health, LLC holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MINT RX. The owner is based in North Palm Beach, FL.

Suite 305

1201 US Highway 1, Suite 305

North Palm Beach, FL 33408

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MINT RX
MINT RX
Registered 2018

Trademark Classifications

Trulee Health, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Trulee Health, LLC have?

Trulee Health, LLC has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Trulee Health, LLC file in?

Trulee Health, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are Trulee Health, LLC's most well-known trademarks?

Trulee Health, LLC's registered trademark portfolio includes well-known marks such as MINT RX. These are among 1 currently registered trademark in the portfolio.

What is Trulee Health, LLC's trademark registration success rate?

Trulee Health, LLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.